$1.41
4.08% yesterday
Nasdaq, Apr 03, 10:17 pm CET
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Theratechnologies Inc. Stock price

$1.41
-0.23 14.02% 1M
+0.20 16.81% 6M
-0.40 22.10% YTD
-0.14 9.03% 1Y
-8.29 85.46% 3Y
-5.27 78.89% 5Y
-1.94 57.91% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.06 4.08%
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Key metrics

Market capitalization $34.12m
Enterprise Value $60.11m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 27.45
EV/Sales (TTM) EV/Sales 0.70
P/S ratio (TTM) P/S ratio 0.40
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 5.02%
Revenue (TTM) Revenue $85.87m
EBIT (operating result TTM) EBIT $7.78m
Free Cash Flow (TTM) Free Cash Flow $2.19m
Cash position $19.62m
EPS (TTM) EPS $-0.19
P/E forward 10.85
P/S forward 0.40
EV/Sales forward 0.70
Short interest 0.13%
Show more

Is Theratechnologies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Theratechnologies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Theratechnologies Inc. forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Theratechnologies Inc. forecast:

Buy
50%
Hold
50%

Financial data from Theratechnologies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Nov '24
+/-
%
86 86
5% 5%
100%
- Direct Costs 22 22
4% 4%
26%
64 64
9% 9%
74%
- Selling and Administrative Expenses 36 36
6% 6%
42%
- Research and Development Expense 17 17
44% 44%
20%
11 11
279% 279%
12%
- Depreciation and Amortization 2.76 2.76
17% 17%
3%
EBIT (Operating Income) EBIT 7.78 7.78
185% 185%
9%
Net Profit -8.31 -8.31
65% 65%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Theratechnologies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Theratechnologies Inc. Stock News

Neutral
GlobeNewsWire
about 17 hours ago
MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results and provide a business update for its first quarter 2025 ended February 28 on Wednesday, April 9, 2025, at 8:30 a.m. ET.
Neutral
GlobeNewsWire
10 days ago
New, improved formulation set to replace EGRIFTA SV® MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) for the F8 formulation ...
Neutral
GlobeNewsWire
23 days ago
MONTREAL, March 12, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today presented data highlighting the limitations of using body mass index (BMI) alone in assessing cardiovascular (CV) risk in people with HIV (PWH). The study underscores the need to incorporate screening for excess ...
More Theratechnologies Inc. News

Company Profile

Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Head office Canada
CEO Paul Lévesque
Employees 105
Founded 1993
Website www.theratech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today